Holen Sie sich die Stockscreener-App
9.22
3.35%
-0.32
Handel nachbörslich:
9.26
0.04
+0.43%
Schlusskurs vom Vortag:
$9.54
Offen:
$9.4
24-Stunden-Volumen:
5.30M
Relative Volume:
0.96
Marktkapitalisierung:
$2.40B
Einnahmen:
$6.29B
Nettoeinkommen (Verlust:
$750.00M
KGV:
3.2014
EPS:
2.88
Netto-Cashflow:
$586.00M
1W Leistung:
+6.10%
1M Leistung:
-29.94%
6M Leistung:
-41.90%
1J Leistung:
-55.97%
1-Tages-Spanne:
$9.17
$9.45
1-Wochen-Bereich:
$8.76
$9.615
52-Wochen-Spanne:
$8.01
$23.10
Organon Co Stock (OGN) Company Profile
Firmenname
Organon Co
Sektor
Telefon
551-430-6000
Adresse
30 HUDSON STREET, JERSEY CITY
Vergleichen Sie OGN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OGN
Organon Co
|
9.22 | 2.26B | 6.29B | 750.00M | 586.00M | 2.88 |
|
LLY
Lilly Eli Co
|
737.67 | 640.72B | 49.00B | 11.11B | -1.27B | 12.29 |
|
JNJ
Johnson Johnson
|
155.21 | 367.98B | 89.33B | 21.81B | 18.57B | 8.99 |
|
ABBV
Abbvie Inc
|
186.11 | 323.71B | 57.37B | 4.20B | 15.39B | 2.35 |
|
NVS
Novartis Ag Adr
|
115.76 | 222.69B | 53.22B | 12.86B | 14.85B | 6.39 |
|
NVO
Novo Nordisk Adr
|
71.50 | 299.26B | 43.59B | 15.04B | 10.74B | 3.3766 |
Organon Co Stock (OGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-02 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2024-09-06 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2023-11-03 | Herabstufung | Goldman | Buy → Neutral |
| 2023-09-21 | Eingeleitet | Barclays | Overweight |
| 2023-03-16 | Eingeleitet | Raymond James | Outperform |
| 2022-10-14 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-09-06 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2022-08-05 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-04-27 | Eingeleitet | Goldman | Buy |
| 2022-04-06 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2021-10-07 | Eingeleitet | Piper Sandler | Neutral |
| 2021-09-01 | Eingeleitet | BofA Securities | Buy |
| 2021-07-22 | Eingeleitet | Citigroup | Buy |
| 2021-06-15 | Eingeleitet | JP Morgan | Neutral |
| 2021-06-11 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2021-06-10 | Eingeleitet | Evercore ISI | Outperform |
Alle ansehen
Organon Co Aktie (OGN) Neueste Nachrichten
OGN Stockholders with Large Losses Should Contact Robbins LLP for Information About the Class Action Lawsuit Against Organon & Co. - WV News
OGN Investors Have Opportunity to Lead Organon & Co. Securities Fraud Lawsuit - PR Newswire
Levi & Korsinsky Urges Organon & Co. (OGN) Shareholders to Act Before Lead Plaintiff Deadline July 22, 2025 - ACCESS Newswire
Class Action Filed Against Organon & Co. (OGN)July 22, 2025 Deadline to Join – Contact Levi & Korsinsky - GlobeNewswire
Law Offices of Howard G. Smith Encourages Organon & Co. (OGN) Investors To Inquire About Securities Fraud Class Action - Business Wire
Did You Lose Money on Organon & Co. (OGN)? Levi & Korsinsky Urges Investors to Act Before July 22, 2025 - ACCESS Newswire
Shareholders who lost money on Organon & Co. (NYSE: OGN). Should Contact Wolf Haldenstein - GlobeNewswire
Shareholders who lost money on Organon & Co. (NYSE: OGN). Should Contact Wolf Haldenstein - GlobeNewswire Inc.
OGN Investors Have the Opportunity to Lead the Organon Securities Fraud Lawsuit with Faruqi & Faruqi, LLP - PR Newswire
Shareholders that lost money on Organon & Co.(OGN) should contact Levi & Korsinsky about pending Class ActionOGN - WV News
Why Organon & Co. (OGN) Surged On Thursday - Insider Monkey
Nuveen Asset Management LLC Reduces Stake in Organon & Co. (NYSE:OGN) - Defense World
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Organon & Co. - GlobeNewswire
Investors who lost money with shares of Organon & Co. (NYSE: OGN) - openPR.com
Levi & Korsinsky Notifies Organon & Co. (OGN) Shareholders of Class Action Lawsuit and July 22, 2025 Deadline - ACCESS Newswire
Shareholders of Organon & Co. Should Contact The Gross Law - GlobeNewswire
Shareholders of Organon & Co. Should Contact The Gross Law Firm Before July 22, 2025 to ... - Bluefield Daily Telegraph
Shareholders of Organon & Co. Should Contact The Gross Law Firm Before July 22, 2025 to Discuss Your Rights – OGN - TradingView
Organon & Co. (OGN) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation - Business Wire
Organon & Co (OGN) Stock Climbs Over 4%: A Value Signal with a Dividend Kicker? - Daily Chhattisgarh News
OGN REMINDER: Organon & Co. Investors with Losses are - GlobeNewswire
OGN REMINDER: Organon & Co. Investors with Losses are Notified of the Pending Securities Fraud Class Action – Contact BFA Law by July 22 Deadline (NYSE:OGN) - TradingView
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of July 22, 2025 in Organon LawsuitOGN - WV News
ORGANON BIOTHERAPEUTICS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Organon & Co.OGN - GlobeNewswire
Investor Alert: Deadline Approaching to Join Organon & Co. (OGN) Class ActionContact Levi & Korsinsky - ACCESS Newswire
Rosen Law Firm Urges Organon & Co. (NYSE: OGN) Stockholders With Large Losses to Contact the Firm for Information About Their Rights - Business Wire
OGN Investors Have the Opportunity to Lead the Organon Securities Fraud Lawsuit with Faruqi ... - Bluefield Daily Telegraph
OGN BREAKING NEWS: Organon & Co. Stock Plummets 27% Triggering Shareholder Class Action – Contact BFA Law if You Lost Money (NYSE:OGN) - Business Wire
OGN Investors Have Opportunity to Lead Organon & Co. Securities Fraud Lawsuit with the Schall Law Firm - WV News
ORGANON SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC ... - Bluefield Daily Telegraph
ORGANON SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Organon & Co. - GlobeNewswire Inc.
OGN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Organon & Co. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - The Malaysian Reserve
OGN INVESTOR ALERT: Organon & Co. Investors with Substantial Los - GuruFocus
Organon Receives FDA Interchangeability for HADLIMA - TipRanks
Drugmaker Organon Investor Sues After Quarterly Dividend Cut (1) - Bloomberg Law News
Sector Update: Health Care - marketscreener.com
Rosen Law Firm Encourages Organon & Co. Investors to Inquire About Securities Class Action Investigation – OGN - Business Wire
Bausch + Lomb, Organon, Globalstar, Telephone and Data Systems, and nLIGHT Shares Skyrocket, What You Need To Know - Yahoo
Organon, Samsung Bioepis Say FDA Grants Interchangeability Designation to Hadlima - marketscreener.com
US Food and Drug Administration (FDA) Grants Interchangeability Designation to Samsung Bioepis and Organon HADLIMA™ (adalimumab-bwwd) Injection - BioSpace
OGN INVESTOR ALERT: Organon & Co. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - Eastern Progress
Organon’s SWOT analysis: healthcare firm’s stock shows growth potential - Investing.com Australia
ORGANON SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Organon & Co.OGN - Business Wire
Organon’s SWOT analysis: healthcare firm’s stock shows growth potential By Investing.com - Investing.com India
OGN INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Organon & Co. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - Business Wire
Organon & Co. (NYSE:OGN) Stock Price Down 4.7% – Should You Sell? - Defense World
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Organon - GlobeNewswire
Lost Money on Organon & Co. (OGN)? Urged to Join Class Action Before July 22, 2025Contact Levi & Korsinsky - ACCESS Newswire
OGN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
Securities Lawsuit Alert: Organon & Co. (OGN) InvestorsContact Levi & Korsinsky Before July 22, 2025 - ACCESS Newswire
Organon & Co. Investor Notice: Robbins LLP Reminds Investors of the Class Action Against OGN - GlobeNewswire
Finanzdaten der Organon Co-Aktie (OGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.17%
0.93%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):